Coronavirus Disease 2019 (COVID-19)
All live meetings are now offered only as webinars; we are not currently scheduling any in-person activities.
All of our enduring activities are open and are available to you through this site.
These 2½- to 3-hour meetings will address the core SCOPE of Pain content, and often include additional content specific to the municipality, region, state, and/or institution serving as collaborating partner.GET STARTED NOW! Select a conference
Daniel P. Alford, MD, MPH
Professor of Medicine
Associate Dean, Continuing Medical Education
Boston University School of Medicine
SCOPE of Pain is a continuing medical education/continuing nursing education activity designed to help you safely and effectively manage patients with acute and/or chronic pain, when appropriate, with opioid analgesics. Through the case of Kathy James, a 32-year-old who has a displaced right femoral neck fracture due to a motor vehicle crash, you'll learn how to:
Physicians, nurse practitioners, registered nurses, physician assistants, nurses, dentists, pharmacists, and allied health professionals whose practices manage acute and chronic pain.
These activities were planned in collaboration with the Council of Medical Specialty Societies (CMSS), the Federation of State Medical Boards (FSMB), Med-IQ Inc., and the National Committee of Quality Assurance (NCQA).
Credit hours will vary depending upon the length of the meeting. Please see registration page for maximum credit amounts.
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
These live activities have been approved for AMA PRA Category 1 Credit™.
Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
The AAFP has reviewed SCOPE of Pain: Safer/Competent Opioid Prescribing Education, and deemed it acceptable for AAFP credit. Term of approval is from 03/01/2021 to 09/30/2021. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Credit approval includes the following session(s):
This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration.
© 2021 Trustees of Boston University. Site by Signal.